Madhu Dewan Khatri, APRN
Adult Health · Reno, NVNPI 1891434841
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 242 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 242 payments — averaging $29.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$1K
- Amgen$998
- Lilly USA, LLC$653
- Bayer$480
- Boehringer Ingelheim$436
- Medtronic$303
- plus $3K from 24 others
Across 2 payments — averaging $5623.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$11K
- Corcept Therapeutics$156
What the payments were for
- Speaking & faculty fees$491%
- Food & beverage$6,99299%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 49 | $1,402 |
| Amgen(2 entities) | 25 | $998 |
| Lilly USA, LLC | 31 | $653 |
| Bayer | 23 | $480 |
| Boehringer Ingelheim | 20 | $436 |
| Medtronic | 7 | $303 |
| AstraZeneca | 8 | $277 |
| Insulet Corporation | 4 | $238 |
| Tandem Diabetes Care, Inc. | 3 | $233 |
| Mannkind Corporation | 11 | $227 |
| Xeris Pharmaceuticals, Inc. | 6 | $212 |
| Sanofi-aventis U.S. LLC | 9 | $204 |
| Antares Pharma, Inc. | 6 | $188 |
| Ascendis Pharma Endocrinology Inc | 3 | $178 |
| Radius Health, Inc. | 8 | $142 |
| Neurocrine Biosciences, Inc. | 1 | $133 |
| BETA Bionics, Inc. | 1 | $125 |
| Novo Nordisk | 5 | $99 |
| Dexcom, Inc. | 3 | $89 |
| AbbVie | 4 | $86 |
| Chiesi USA, Inc. | 3 | $57 |
| Soleno Therapeutics, Inc. | 2 | $53 |
| Madrigal Pharmaceuticals | 1 | $48 |
| Kyowa Kirin, Inc. | 2 | $46 |
| IBSA Pharma Inc. | 2 | $34 |
| Recordati_rare_diseases_inc. | 1 | $32 |
| Amryt Pharma Holdings Ltd | 1 | $23 |
| Sequel Med Tech, LLC | 1 | $22 |
| Cordis US CORP. | 1 | $19 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Korlym$596
- iLet Bionic Pancreas$374
- TEPEZZA$336
- Prolia$221
- CRENESSITY$133
- iLet Insulin Infusion Kit Inset$125
- iLet Insulin Infusion Kit Contact Detach$125
- RECORLEV$123
- t:slim X2 Insulin Pump with Control-IQ$117
- EVENITY$115
- Omnipod$114
- Kerendia$110
- XYOSTED$107
How this compares
$7,052 in reported general payments places this provider in the 90th percentile of 90 adult health providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 61 | $112,920 |
| JardianceEmpagliflozin | 54 | $66,176 |
| Teriparatide | 23 | $65,206 |
| MounjaroTirzepatide | 28 | $40,105 |
| Tresiba Flextouch U-200Insulin Degludec | 21 | $33,668 |
| Tresiba Flextouch U-100Insulin Degludec | 19 | $25,495 |
| KerendiaFinerenone | 17 | $24,816 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 27 | $15,518 |
| TradjentaLinagliptin | 15 | $9,410 |
| FarxigaDapagliflozin Propanediol | 13 | $9,301 |
| SynthroidLevothyroxine Sodium | 35 | $3,773 |
| Levothyroxine Sodium | 157 | $2,053 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 15 | $2,000 |
| Methimazole | 67 | $1,320 |
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 11 | $1,151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $99 | $112,92061 claims |
| Boehringer IngelheimJardiance, Tradjenta | $436 | $75,58669 claims |
| Lilly USA, LLCMounjaro | $653 | $40,10528 claims |
| BayerKerendia | $480 | $24,81617 claims |
| AstraZenecaFarxiga | $277 | $9,30113 claims |
| AbbVieSynthroid | $86 | $3,77335 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 90 adult health providers in Nevada.
Other adult health in Reno
- Stephanie CarlsenReno$9K
- Rommel CoReno$6K
- Samantha PotencianoReno$3K
- Edin AbdagicReno$3K
- Lindsay ByrneReno$2K
- Valerie JakubosReno$1K
- Brittany BeaumierReno$1K
- Renee HinojosaReno$1K
- Hector JoseReno$956
- Jessica WilkinsonReno$867
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.